The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Diabetes, Hypertension, and Cardiovascular Disease: An Update
Open accessAbstract
Abstract —Cardiovascular diseases (CVDs) are the major causes of mortality in persons with diabetes, and many factors, including hypertension, contribute to this high prevalence of CVD. Hypertension is approximately twice as frequent in patients with diabetes compared with patients without the disease. Conversely, recent data suggest that hypertensive persons are more predisposed to the development of diabetes than are normotensive persons. Furthermore, up to 75% of CVD in diabetes may be attributable to hypertension, leading to recommendations for more aggressive treatment (ie, reducing blood pressure to <130/85 mm Hg) in persons with coexistent diabetes and hypertension. Other important risk factors for CVD in these patients include the following: obesity, atherosclerosis, dyslipidemia, microalbuminuria, endothelial dysfunction, platelet hyperaggregability, coagulation abnormalities, and “diabetic cardiomyopathy.” The cardiomyopathy associated with diabetes is a unique myopathic state that appears to be independent of macrovascular/microvascular disease and contributes significantly to CVD morbidity and mortality in diabetic patients, especially those with coexistent hypertension. This update reviews the current knowledge regarding these risk factors and their treatment, with special emphasis on the cardiometabolic syndrome, hypertension, microalbuminuria, and diabetic cardiomyopathy. This update also examines the role of the renin-angiotensin system in the increased risk for CVD in diabetic patients and the impact of interrupting this system on the development of clinical diabetes as well as CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,094
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
(2000) · PubMed · Cited by 2,095
Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmäki, K., Dahlöf, B., de Faire, U., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 2,014
Turner, R. D., & Holman, R. R. (1998) · Cited by 1,974
Cited by
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.013 · Cited by 1,555
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Self-citationJellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Self-citationClinical Practice Recommendations
Fowler, M. J. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.163 · Cited by 995
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Fang, Z. Y., Prins, J. B., & Marwick, T. H. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0012 · Cited by 912
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318277d6a0 · Cited by 845
Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes
Lurbe, E., Redon, J., Kesani, A., Pascual, J. M., Tacons, J., Alvarez, V., & Batlle, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013410 · Cited by 729
Kenny, H. C., & Abel, E. D. (2019) · Circulation Research · doi:10.1161/circresaha.118.311371 · Cited by 660
Jellinger, P. S., Smith, D. A., Mehta, A. E., Ganda, O., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., & Seibel, J. A. (2012) · Endocrine Practice · doi:10.4158/ep.18.s1.1 · Cited by 533
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
Verdecchia, P., Reboldi, G., Angeli, F., Borgioni, C., Gattobigio, R., Filippucci, L., Norgiolini, S., Bracco, C., & Porcellati, C. (2004) · Hypertension · doi:10.1161/01.hyp.0000125726.92964.ab · Cited by 510
Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes
Sheard, N. F., Clark, N. G., Brand-Miller, J. C., Franz, M. J., Pi-Sunyer, F. X., Mayer-Davis, E., Kulkarni, K., & Geil, P. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2266 · Cited by 475
Insulin resistance and hypertension
Sowers, J. R. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00026.2004 · Cited by 471
Self-citationEmpagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension
Tikkanen, I., Narko, K., Zeller, C., Green, A., Salsali, A., Broedl, U. C., & Woerle, H. J. (2015) · Diabetes Care · doi:10.2337/dc14-1096 · Cited by 468
Insulin resistance in chronic kidney disease: a systematic review
Spoto, B., Pisano, A., & Zoccali, C. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00340.2016 · Cited by 450
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
An, D., & Rodrigues, B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00278.2006 · Cited by 446
Qaseem, A., Fihn, S. D., Williams, S., Dallas, P., Owens, D. K., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00010 · Cited by 393
Oxidative Stress and Diabetic Cardiomyopathy: A Brief Review
Cai, L., & Kang, Y. J. (2001) · Cardiovascular Toxicology · doi:10.1385/ct:1:3:181 · Cited by 376
Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links
De Rosa, S., Arcidiacono, B., Chiefari, E., Brunetti, A., Indolfi, C., & Foti, D. P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00002 · Cited by 369
Falcão-Pires, I., & Leite-Moreira, A. F. (2012) · Heart Failure Reviews · doi:10.1007/s10741-011-9257-z · Cited by 363
What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
Satchell, S. C., & Tooke, J. E. (2008) · Diabetologia · doi:10.1007/s00125-008-0961-8 · Cited by 361
α-Glucosidase Inhibitory Profile of Catechins and Theaflavins
Matsui, T., Tanaka, T., Tamura, S., Toshima, A., Tamaya, K., Miyata, Y., Tanaka, K., & Matsumoto, K. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0627672 · Cited by 341
Hwang, J., Ing, M. H., Salazar, A., Lassègue, B., Griendling, K., Navab, M., Sevanian, A., & Hsiai, T. K. (2003) · Circulation Research · doi:10.1161/01.res.0000104087.29395.66 · Cited by 334
Carroll, S., & Dudfield, M. (2004) · Sports Medicine · doi:10.2165/00007256-200434060-00004 · Cited by 327
Bloomgarden, Z. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.998 · Cited by 325
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Cooper, S. A., Whaley-Connell, A., Habibi, J., Wei, Y., Lastra, G., Manrique, C., Stas, S., & Sowers, J. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00522.2007 · Cited by 317
Self-citationType 2 Diabetes Mellitus and Hypertension
Lastra, G., Syed, S., Kurukulasuriya, L. R., Manrique, C., & Sowers, J. R. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.005 · Cited by 307
Self-citationPrevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
Scheen, A. J. (2004) · Drugs · doi:10.2165/00003495-200464220-00004 · Cited by 293
Why blockade of the renin–angiotensin system reduces the incidence of new-onset diabetes
Jandeleit-Dahm, K. A., Tikellis, C., Reid, C. M., Johnston, C. I., & Cooper, M. E. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000160198.05416.72 · Cited by 293
New-onset diabetes and antihypertensive drugs
Mancia, G., Grassi, G., & Zanchetti, A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000194119.42722.21 · Cited by 293
Inflamm-aging does not simply reflect increases in pro-inflammatory markers
Morrisette-Thomas, V., Cohen, A. A., Fülöp, T., Riesco, É., Legault, V., Li, Q., Milot, E., Dusseault-Bélanger, F., & Ferrucci, L. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.06.005 · Cited by 283
Ni, R., Cao, T., Xiong, S., Ma, J., Fan, G.-C., Lacefield, J. C., Lu, Y., Tissier, S. L., & Peng, T. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.013 · Cited by 288
Impact of genetic background on nephropathy in diabetic mice
Gurley, S. B., Clare, S. E., Snow, K. P., Hu, A., Meyer, T. W., & Coffman, T. M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00204.2005 · Cited by 286
Honda, H., Qureshi, A. R., Axelsson, J., Heimburger, O., Suliman, M. E., Barany, P., Stenvinkel, P., & Lindholm, B. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.633 · Cited by 282
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Zhou, J., Jiang, X., He, S., Jiang, H., Feng, F., Liu, W., Qu, W., & Sun, H. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00017 · Cited by 281
Jonk, A. M., Houben, A. J. H. M., de Jongh, R. T., Serné, E. H., Schaper, N. C., & Stehouwer, C. D. A. (2007) · Physiology · doi:10.1152/physiol.00012.2007 · Cited by 280
Mechanisms of cardiac dysfunction in obstructive sleep apnea
Baguet, J.-P., Barone-Rochette, G., Tamisier, R., Levy, P., & Pépin, J.-L. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.141 · Cited by 275
QUAGLIARO, L., PICONI, L., ASSALONI, R., DAROS, R., MAIER, A., ZUODAR, G., & CERIELLO, A. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.015 · Cited by 268
Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes
Hu, G., Jousilahti, P., Barengo, N. C., Qiao, Q., Lakka, T. A., & Tuomilehto, J. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.799 · Cited by 265
Peroxisome Proliferator-Activated Receptor-γ–Mediated Effects in the Vasculature
Duan, S. Z., Usher, M. G., & Mortensen, R. M. (2008) · Circulation Research · doi:10.1161/circresaha.107.164384 · Cited by 263
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus
Scheen, A. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70146-5 · Cited by 252
Attaei, M. W., Khatib, R., McKee, M., Lear, S., Dagenais, G., Igumbor, E. U., AlHabib, K. F., Kaur, M., Kruger, L., Teo, K., et al. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30141-x · Cited by 209
Hitomi, H., Kiyomoto, H., Nishiyama, A., Hara, T., Moriwaki, K., Kaifu, K., Ihara, G., Fujita, Y., Ugawa, T., & Kohno, M. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.093955 · Cited by 140
Perceived discrimination and markers of cardiovascular risk among low‐income African American youth
Goosby, B. J., Malone, S., Richardson, E. A., Cheadle, J. E., & Williams, D. T. (2015) · American Journal of Human Biology · doi:10.1002/ajhb.22683 · Cited by 127
Diabetes, hypertension, and cardiovascular derangements: Pathophysiology and management
El-Atat, F., McFarlane, S. I., & Sowers, J. R. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0072-y · Cited by 121
Self-citationHendijani, F., & Akbari, V. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.02.015 · Cited by 122
Lebeche, D., Davidoff, A. J., & Hajjar, R. J. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1347 · Cited by 122
Eringa, E. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00593-x · Cited by 118
Eringa, E. C., Stehouwer, C. D. A., van Nieuw Amerongen, G. P., Ouwehand, L., Westerhof, N., & Sipkema, P. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00067.2004 · Cited by 107
Sjöström, C. D., Johansson, P., Ptaszynska, A., List, J., & Johnsson, E. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115585298 · Cited by 97
Bakris, G. L., Weir, M. R., & on behalf of the Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) Investigators (2003) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.2041.x · Cited by 94
Giordano, D., Corrado, F., Santamaria, A., Quattrone, S., Pintaudi, B., Di Benedetto, A., & D'Anna, R. (2011) · Menopause · doi:10.1097/gme.0b013e3181e8e1b1 · Cited by 89
Exercise capacity and body mass as predictors of mortality among male veterans with type 2 diabetes
McAuley, P. A., Myers, J. N., Abella, J. P., Tan, S. Y., & Froelicher, V. F. (2007) · Diabetes Care · doi:10.2337/dc06-2397 · Cited by 69
Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance
Quilliot, D., Alla, F., Böhme, P., Bruntz, J.-F., Hammadi, M., Dousset, B., Ziegler, O., & Zannad, F. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803022 · Cited by 61
van Son, J., Nyklíček, I., Pop, V. J., & Pouwer, F. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-131 · Cited by 55
“This is unfavorable for patients with diabetes, as the prevalence of high blood pressure in people with diabetes is approximately twice as high compared to the general population [30] and both diabetes and high blood pressure are important risk factors for cardiovascular disease [30].”
BackgroundCardiometabolic Risk Factors Assessed by a Finger Stick Dried Blood Spot Method
Kapur, S., Kapur, S., & Zava, D. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200210 · Cited by 45
Cardiovascular Risk Factors Associated with Insulin Resistance: Effects of Oral Antidiabetic Agents
Granberry, M. C., & Fonseca, V. A. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505030-00006 · Cited by 38
(2006) · PubMed Central · Cited by 36
McFarlane, S. I., Shin, J. J., Rundek, T., & Bigger, J. T. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0070-5 · Cited by 28
US Trends in Glycemic Control, Treatment, and Comorbidity Burden in Patients With Diabetes
Shaya, F. T., Yan, X., Lin, P., Simoni‐Wastila, L., Bron, M., Baran, R., & Donner, T. W. (2010) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00365.x · Cited by 29
Chang, K.-C., Shao, S.-C., Kuo, S., Yang, C.-Y., Chen, H.-Y., Chan, Y.-Y., & Ou, H.-T. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01148-8 · Cited by 28
Gu, Y., Bao, X., Wang, Y., Meng, G., Wu, H., Zhang, Q., Liu, L., Song, K., Wang, Y., & Niu, K. (2020) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2019-212531 · Cited by 13
Equity and AI Governance at Academic Medical Centers
(2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89555 · Cited by 12
Synthesis of thiazolidinedione compound library
Damkaci, F., Szymaniak, A. A., Biasini, J. P., & Cotroneo, R. (2022) · Compounds · doi:10.3390/compounds2030013 · Cited by 8
Zhang, J., Tong, A., Dai, Y., Niu, J., Yu, F., & Xu, F. (2019) · The Journal of Clinical Hypertension · doi:10.1111/jch.13598 · Cited by 5
AbdulAbbas, A. M., Alkanany, R., Al-Nuaimi, Y. A. K., & Al-Hamdawee, Z. M. A. (2025) · Engineering, Technology & Applied Science Research · doi:10.48084/etasr.14155 · Cited by 3
Metadata
- Authors
- Sowers, J. R., Epstein, M., & Frohlich, E. D.
- Venue
- Hypertension
- Published
- 2001-04
- Volume
- 37
- Issue
- 4
- Pages
- 1053-1059
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2023531846
- Cited by
- 1,332
- References
- 57
- FWCI
- 36.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.